We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 23% below its sector, cheaper than its peers on earnings.
Ame Company For Medical Supplies operates as a distributor and marketer of medical products specifically designed for the aesthetic market throughout Saudi Arabia. Its comprehensive product catalog features a variety of key offerings, including Teoxane, a line of injectable hyaluronic acid-based dermal fillers formulated to reduce wrinkles on the face and neck. The company also provides advanced medical laser systems, innovative therapeutic solutions, and various botulinum products. Furthermore, their portfolio encompasses Magellan, an autologous concentration system for delivering focused platelets and cells at the point of care, as well as MINT, an absorbable polydioxanone barbed suture used for soft tissue approximation. Established in 2005, the firm is headquartered in Jeddah, Saudi Arabia.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 9527.SR and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
